In the literature, miR-93 (the precursor of miR-93-5p) has been shown to target Matrix Metalloproteinase 3 (MMP3) and Vascular Endothelial Growth Factor A (VEGF-A), which are involved in endometriosis by contributing to tissue remodeling, angiogenesis, and the proliferation of endometriotic lesions [46]. Here, VEGFA is linked to endometriosis.